Study of XJH05 ointment for mild-to-moderate plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have plaque psoriasis (the most common type with thick, scaly patches).
- Your psoriasis should be mild to moderate, covering up to 10% of your body surface area (roughly the size of your palms).
- You must not have other forms of psoriasis, such as erythrodermic, pustular, or generalized guttate psoriasis.
- You must not have used systemic (pills or injections) psoriasis treatments, biologics, or topical steroids/retinoids recently (within the washout period).
- You must not have an active skin infection at the treatment area or be allergic to the study ointment or its ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication called GM-XANTHO [GM-XAN003] to see if it is safe and effective for people with mild to moderate plaque psoriasis. Participants will use the study drug themselves and must stop other psoriasis treatments during the study.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.